Details

Autor(en) / Beteiligte

• Kanyama, Cecilia
• Molloy, Síle F
• Chan, Adrienne K
• Lupiya, Duncan
• Chawinga, Chimwemwe
• Adams, Jack
• Bright, Philip
• Lalloo, David G
• Heyderman, Robert S
• Lortholary, Olivier
• Jaffar, Shabbar
• Loyse, Angela
• van Oosterhout, Joep J
• Hosseinipour, Mina C
• Harrison, Thomas S

Titel

One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi

Ist Teil von

• Clinical infectious diseases, 2020-01, Vol.70 (3), p.521-524

Ort / Verlag

US: Oxford University Press

Erscheinungsjahr

2020

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract In Malawi, 236 participants from the Advancing Cryptococcal Meningitis Treatment for Africa trial were followed for 12 months. The trial outcomes reported at 10 weeks were sustained to 1 year. One-week amphotericin B plus flucytosine was associated with the lowest 1 year mortality (27.5% [95% confidence interval, 16.3 to 44.1]).